Industry News | tctmd.com

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

October 29, 2013

News Industry News

Boston Scientific Launches OffRoad™ Re-Entry Catheter System

February 04, 2014

News Industry News

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

January 05, 2014

News Industry News

Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent

January 14, 2014

News Industry News

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

October 31, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

Covidien to Exit OneShot™ Renal Denervation Program

January 20, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Industry News

New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting

October 31, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Subscribe to Industry News

Advertisement

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

Boston Scientific Launches OffRoad™ Re-Entry Catheter System

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent

Second Generation Transcatheter Aortic Valve Shown to Successfully Address Complications of TAVR

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

Covidien to Exit OneShot™ Renal Denervation Program

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content